Clinical Trial Update: Positron Emission Tomography (PET) Study to Describe the Relationship Between Plasma Concentrations and Brain Gly-T1 Occupancy of GSK1018921 Over Time. [Phase 1]

View source ↗

Summary

This Phase 1 PET study investigates the relationship between plasma concentrations of GSK1018921 and brain Gly-T1 occupancy in individuals with schizophrenia. T…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• GSK1018921

Snippet

Sponsor: GlaxoSmithKline | Conditions: Schizophrenia | Phase 1 | Status: COMPLETED